Patients with DCM and lower myocardial HTRA2 expression had lower ageHTx/LVAD by 5.1 years, and lower SPG7 displayed only a trend for reduced ageHTx/LVAD. This evidence concerns the gene HTRA2 and familial dilated cardiomyopathy.